Similar articles

• Modification of the ocular immune response. I. Use of antilymphocytic serum to prevent immune rejection of penetrating corneal homografts.

  Waltman SR, Faulkner HW, Burde RM. Waltman SR, et al. Invest Ophthalmol. 1969 Apr;8(2):196-200. Invest Ophthalmol. 1969. PMID: 4887870 No abstract available.
• Suppression of corneal graft reaction by antilymphocyte serum. 3. Effect of pretreatment of donor animals.

  Smolin G, Hyndiuk RA. Smolin G, et al. Arch Ophthalmol. 1971 Apr;85(4):451-4. doi: 10.1001/archopht.1971.00990050453011. Arch Ophthalmol. 1971. PMID: 4929072 No abstract available.
• [Antilymphocytic serum].

  [No authors listed] [No authors listed] Policlinico Prat. 1968 Jul 1;75(27):883-6. Policlinico Prat. 1968. PMID: 4174248 Italian. No abstract available.
• Mode of action of antilymphocyte serum.

  DeMeester TR. DeMeester TR. Surg Gynecol Obstet. 1969 Oct;129(4):717-22. Surg Gynecol Obstet. 1969. PMID: 4898242 Review. No abstract available.
• Recent developments in transplantation immunology. II.

  Billingham RE, Barker CF. Billingham RE, et al. Plast Reconstr Surg. 1969 Jul;44(1):20-9. doi: 10.1097/00006534-196907000-00003. Plast Reconstr Surg. 1969. PMID: 4893007 Review. No abstract available.